80 related articles for article (PubMed ID: 10498244)
1. In vitro analysis of transformation potential associated with retroviral vector insertions.
Powell SK; Kaloss M; Burimski I; Weaver L; Long Z; Lyons R; McGarrity GJ; Otto E
Hum Gene Ther; 1999 Sep; 10(13):2123-32. PubMed ID: 10498244
[TBL] [Abstract][Full Text] [Related]
2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
3. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
[TBL] [Abstract][Full Text] [Related]
4. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
5. A single treatment with IL-4 via retrovirally transduced lymphocytes partially protects against diabetes in BioBreeding (BB) rats.
Zipris D; Karnieli E
JOP; 2002 May; 3(3):76-82. PubMed ID: 12004164
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vector production.
Miller AD
Curr Protoc Hum Genet; 2014 Jan; 80():12.5.1-12.5.22. PubMed ID: 24510681
[TBL] [Abstract][Full Text] [Related]
8. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
[TBL] [Abstract][Full Text] [Related]
9. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.
Modlich U; Schambach A; Brugman MH; Wicke DC; Knoess S; Li Z; Maetzig T; Rudolph C; Schlegelberger B; Baum C
Leukemia; 2008 Aug; 22(8):1519-28. PubMed ID: 18496560
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
11. Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene.
Li Z; Kustikova OS; Kamino K; Neumann T; Rhein M; Grassman E; Fehse B; Baum C
Ann N Y Acad Sci; 2007 Jun; 1106():95-113. PubMed ID: 17395733
[TBL] [Abstract][Full Text] [Related]
12. Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.
Reeves L; Smucker P; Cornetta K
Hum Gene Ther; 2000 Oct; 11(15):2093-103. PubMed ID: 11044911
[TBL] [Abstract][Full Text] [Related]
13. Development of retroviral vectors for insertional mutagenesis in medaka haploid cells.
Lin F; Liu Q; Yuan Y; Hong Y
Gene; 2015 Dec; 573(2):296-302. PubMed ID: 26192464
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.
Li KQ; Li WL; Peng SY; Shi XY; Tang HL; Liu YB
Chin Med J (Engl); 2004 Sep; 117(9):1364-9. PubMed ID: 15377430
[TBL] [Abstract][Full Text] [Related]
16. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
[TBL] [Abstract][Full Text] [Related]
17. Mutations in p53 cDNA sequence introduced by retroviral vector.
Su S; Watanabe A; Yamamoto M; Nakajima E; Miyake K; Shimada T
Biochem Biophys Res Commun; 2006 Feb; 340(2):567-72. PubMed ID: 16380088
[TBL] [Abstract][Full Text] [Related]
18. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
19. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo.
Bilbao G; Feng M; Rancourt C; Jackson WH; Curiel DT
FASEB J; 1997 Jul; 11(8):624-34. PubMed ID: 9240964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
